I.M. Visman

517 total citations
20 papers, 325 citations indexed

About

I.M. Visman is a scholar working on Rheumatology, Hematology and Epidemiology. According to data from OpenAlex, I.M. Visman has authored 20 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 5 papers in Hematology and 3 papers in Epidemiology. Recurrent topics in I.M. Visman's work include Rheumatoid Arthritis Research and Therapies (14 papers), Spondyloarthritis Studies and Treatments (12 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). I.M. Visman is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (14 papers), Spondyloarthritis Studies and Treatments (12 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). I.M. Visman collaborates with scholars based in Netherlands, United States and Greece. I.M. Visman's co-authors include Michael T. Nurmohamed, Ben A. C. Dijkmans, Irene E. van der Horst‐Bruinsma, Matthew Peters, J. Christiaan van Denderen, Willem F. Lems, Maria S.A. Suttorp-Schulten, Robert Verheij, M. Nielen and Irene van der Horst‐Bruinsma and has published in prestigious journals such as Journal of Bone and Mineral Research, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

I.M. Visman

19 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I.M. Visman Netherlands 9 256 90 61 38 34 20 325
Muhammad Azaan Khan Australia 7 242 0.9× 107 1.2× 78 1.3× 17 0.4× 26 0.8× 23 341
Linda Carli Italy 11 195 0.8× 95 1.1× 31 0.5× 28 0.7× 7 0.2× 19 288
S. Yılmaz-Öner Türkiye 11 187 0.7× 78 0.9× 60 1.0× 37 1.0× 34 1.0× 27 290
G. Özen Türkiye 9 113 0.4× 59 0.7× 35 0.6× 32 0.8× 97 2.9× 17 257
Andrea Cuervo Spain 12 274 1.1× 167 1.9× 100 1.6× 135 3.6× 8 0.2× 31 439
J. Sieper Germany 8 520 2.0× 287 3.2× 132 2.2× 30 0.8× 6 0.2× 15 585
Hyun Kyu Chang South Korea 12 238 0.9× 32 0.4× 59 1.0× 29 0.8× 244 7.2× 27 412
Gianna Mennillo Italy 6 232 0.9× 83 0.9× 52 0.9× 54 1.4× 13 0.4× 9 279
Petra Hánová Czechia 11 229 0.9× 127 1.4× 91 1.5× 91 2.4× 4 0.1× 21 373
A. Valenzuela Spain 7 116 0.5× 159 1.8× 21 0.3× 32 0.8× 4 0.1× 11 342

Countries citing papers authored by I.M. Visman

Since Specialization
Citations

This map shows the geographic impact of I.M. Visman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.M. Visman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.M. Visman more than expected).

Fields of papers citing papers by I.M. Visman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I.M. Visman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.M. Visman. The network helps show where I.M. Visman may publish in the future.

Co-authorship network of co-authors of I.M. Visman

This figure shows the co-authorship network connecting the top 25 collaborators of I.M. Visman. A scholar is included among the top collaborators of I.M. Visman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I.M. Visman. I.M. Visman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Joustra, V, Hilal Sengül, Peter Henneman, et al.. (2023). Novel DNA methylome biomarkers associated with adalimumab response in rheumatoid arthritis patients. Frontiers in Immunology. 14. 1303231–1303231. 6 indexed citations
3.
Konsta, Maria, Michael T. Nurmohamed, Alexios Iliopoulos, et al.. (2022). Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors. The Journal of Rheumatology. 50(3). jrheum.220061–jrheum.220061. 2 indexed citations
4.
Visman, I.M., et al.. (2022). The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study. Clinical Rheumatology. 41(12). 3747–3752. 2 indexed citations
5.
Visman, I.M., et al.. (2020). Favorable effects on the hemostatic system in ankylosing spondylitis patients treated with golimumab. Joint Bone Spine. 88(2). 105102–105102. 1 indexed citations
6.
Rusman, Tamara, J. Christiaan van Denderen, Maria Konsta, et al.. (2019). Long-Term Treatment With TNF-Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis. Journal of Bone and Mineral Research. 34(6). 1041–1048. 31 indexed citations
7.
Ibañez, Sebastián, et al.. (2017). Muscle wasting in male TNF-α blocker naïve ankylosing spondylitis patients: a comparison of gender differences in body composition. Lara D. Veeken. 56(9). 1566–1572. 25 indexed citations
8.
Ibañez, Sebastián, Michael T. Nurmohamed, I.M. Visman, et al.. (2017). Fat Mass Lowers the Response to Tumor Necrosis Factor-α Blockers in Patients with Ankylosing Spondylitis. The Journal of Rheumatology. 44(9). 1355–1361. 19 indexed citations
9.
Rusman, Tamara, et al.. (2017). THU0391 Female gender is associated with a poorer response to tnf inhibitors in ankylosing spondylitis. Annals of the Rheumatic Diseases. 76. 354–355. 3 indexed citations
10.
Kneepkens, E., et al.. (2017). Long-term treatment response in rheumatoid arthritis patients starting adalimumab or etanercept with or without concomitant methotrexate.. PubMed. 35(3). 431–437. 6 indexed citations
11.
Visman, I.M., et al.. (2015). AB0457 Patient Reported Adverse Events on Rituximab Treatment for Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 74. 1048–1049.
12.
Claushuis, Theodora A. M., Mirjam K. de Vries, I.M. Visman, et al.. (2015). C-reactive protein polymorphisms influence serum CRP-levels independent of disease activity in ankylosing spondylitis.. PubMed. 33(2). 159–65. 14 indexed citations
13.
Denderen, J. Christiaan van, I.M. Visman, Michael T. Nurmohamed, Maria S.A. Suttorp-Schulten, & Irene van der Horst‐Bruinsma. (2014). Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis. The Journal of Rheumatology. 41(9). 1843–1848. 47 indexed citations
14.
Visman, I.M., et al.. (2013). THU0201 The Influence of Body Mass Index on the Efficacy of TNF-Alpha Blocking Therapy in Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 72. A231–A232. 1 indexed citations
15.
Sijl, Alper M. van, I.M. Visman, Matthew Peters, et al.. (2012). FRI0142 TNF-blocking therapy reduces cardiovascular disease and risk factors in rheumatoid arthritis. Annals of the Rheumatic Diseases. 71. 358–358. 1 indexed citations
16.
Visman, I.M., G. M. Bartelds, Wouter Ouwerkerk, et al.. (2011). Effect of the Application of Trial Inclusion Criteria on the Efficacy of Adalimumab Therapy in a Rheumatoid Arthritis Cohort. The Journal of Rheumatology. 38(9). 1884–1890. 1 indexed citations
17.
Horst‐Bruinsma, Irene E. van der, J. Christiaan van Denderen, I.M. Visman, et al.. (2010). Decreased Recurrence Rate of Anterior Uveitis in Ankylosing Spondylitis Treated with Adalimumab - An Interim Analysis. Clinical and Experimental Rheumatology. 28(4). 630–630. 8 indexed citations
18.
Jamnitski, Anna, I.M. Visman, Matthew Peters, et al.. (2010). Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study. Annals of the Rheumatic Diseases. 69(11). 1929–1933. 43 indexed citations
19.
Peters, Matthew, I.M. Visman, M. Nielen, et al.. (2009). Ankylosing spondylitis: a risk factor for myocardial infarction?. Annals of the Rheumatic Diseases. 69(3). 579–581. 82 indexed citations
20.
Nurmohamed, Michael T., et al.. (2007). Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 67(2). 256–259. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muhammad Azaan Khan Breakdown of academic impact, for papers by Linda Carli Breakdown of academic impact, for papers by S. Yılmaz-Öner Breakdown of academic impact, for papers by G. Özen Breakdown of academic impact, for papers by Andrea Cuervo Breakdown of academic impact, for papers by J. Sieper Breakdown of academic impact, for papers by Hyun Kyu Chang Breakdown of academic impact, for papers by Gianna Mennillo Breakdown of academic impact, for papers by Petra Hánová Breakdown of academic impact, for papers by A. Valenzuela
Rankless by CCL
2026